Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2018 Jul 25;25(6):450. doi: 10.1038/s41434-018-0031-x

Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65

A Georgiadis 1, Y Duran 1, J Ribeiro 1, L Abelleira-Hervas 1, S J Robbie 1, B Sünkel-Laing 1, S Fourali 1, A Gonzalez-Cordero 1, E Cristante 1, M Michaelides 1,2, J W B Bainbridge 1,2, A J Smith 1, R R Ali 1,2,✉
PMCID: PMC6328849  PMID: 30046128

Correction to: Gene Therapy 10.1038/gt.2016.66, published online 22 September 2016

This Article was originally published under a CC BY-NC-SA 4.0 license, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the Article have been modified accordingly.


Articles from Gene Therapy are provided here courtesy of Nature Publishing Group

RESOURCES